Showing results (51-60 of 577) with videos related to
Sort By:
Pageof 58
American Journal of Hypertension|March 1, 1991
Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertensionW H Sheu, A L Swislocki, B Hoffman, et al.Journal of Internal Medicine|September 1, 1992
Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in womenF Facchini, C B Hollenbeck, Y N Chen, et al.Diabetes|August 1, 1988
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDMG M Reaven, C Hollenbeck, C Y Jeng, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1985
How insulin resistant are patients with noninsulin-dependent diabetes mellitus?G M Reaven, Y D Chen, C C Donner, et al.Atherosclerosis|September 1, 1987
Plasma lipid and lipoprotein concentrations in Chinese males with coronary artery disease, with and without hypertensionS M Shieh, M Shen, M M Fuh, et al.The Journal of Clinical Endocrinology and Metabolism|April 1, 1987
Can insulin resistance exist as a primary defect in noninsulin-dependent diabetes mellitus?A L Swislocki, C C Donner, E Fraze, et al.Diabetologia|August 1, 1987
Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetesA L Swislocki, Y D Chen, A Golay, et al.Diabetes|July 1, 1984
Insulin-stimulated glucose disposal increases with time in patients with non-insulin-dependent diabetes mellitusG Liu, Y D Chen, C B Hollenbeck, et al.Diabete & Metabolisme|September 1, 1991
Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteriaC B Hollenbeck, P Johnston, B B Varasteh, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1991
Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetesR Skowronski, C B Hollenbeck, B B Varasteh, et al.Pageof 58